Medeor Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Medeor Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants (NCT03606746) | Medeor Therapeutics, Inc. | 2024-12-01 |
| Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants (NCT03605654) | Medeor Therapeutics, Inc. | 2024-12-01 |
| Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products (NCT05010174) | Medeor Therapeutics, Inc. | 2022-05-11 |
| Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants (NCT03363945) | Medeor Therapeutics, Inc. | 2018-03-15 |
Track Medeor Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.